TITLE

Clinical evaluation of plasma exchange and high dose intravenous immunoglobulin in a patient with Isaacs' syndrome

AUTHOR(S)
Ishii, A; Hayashi, A; Ohkoshi, N; Oguni, E; Maeda, M; Ueda, Y; Ishii, K; Arasaki, K; Mizusawa, H; Shoji, S
PUB. DATE
July 1994
SOURCE
Journal of Neurology, Neurosurgery & Psychiatry;Jul1994, Vol. 57 Issue 7, p840
SOURCE TYPE
Academic Journal
DOC. TYPE
journal article
ABSTRACT
No abstract available.
ACCESSION #
66087034

 

Related Articles

  • Successful treatment of a hypothalamic lesion in neuromyelitis optica by plasma exchange. Watanabe, Shohei; Nakashima, Ichiro; Miyazawa, Isabelle; Misu, Tatsuro; Shiga, Yusei; Nakagawa, Yoichi; Fujihara, Kazuo; Itoyama, Yasuto // Journal of Neurology;May2007, Vol. 254 Issue 5, p670 

    A letter to the editor is presented regarding the therapeutic efficacy of plasma exchange for a hypothalamic lesion in a neuromyelitis optica-immunoglobulin G-positive neuromyelitis optica patient who is totally unresponsive to high-dose intravenous methylprednisolone.

  • Catastrophic antiphospholipid (Asherson's) syndrome. Cervera, Ricard; Asherson, Ronald A. // British Journal of Hospital Medicine (17508460);Jul2008, Vol. 69 Issue 7, p384 

    The article discusses characteristics and treatment of catastrophic antiphospholipid syndrome. The author stated that the condition is a potentially life-threatening condition with a high mortality. He added that the current basic treatment of the condition is the combination of high doses of...

  • GENERAL CONSIDERATION OF GUILLIAIN BARRE SYNDROME. Gandhi, Zeel A.; Maisuria, Brijal A.; Patel, Rajesh G.; Arora, Bhoomi // International Journal of Pharmaceutical Sciences & Research;Nov2012, Vol. 3 Issue 11, p4135 

    Guillain-Barré syndrome is a rare but important disease that can lead to life threatening respiratory failure. This review summarises the verified consideration of Guillain-Barré syndrome (GBS) which are thought to be caused by direct autoimmune attack on peripheral nerves. Aim- Nerve...

  • Intravenous Immunoglobulin G Therapy in Streptococcal Toxic Shock Syndrome: A European Randomized, Double-Blind, Placebo-Controlled Trial. Darenberg, Jessica; Ihendyane, Nahla; Sjölin, Jan; Aufwerber, Ewa; Haidl, Sven; Follin, Per; Andersson, Jan; Norrby-Teglund, Anna // Clinical Infectious Diseases;8/1/2003, Vol. 37 Issue 3, p333 

    Evaluates the efficacy and safety of high-dose intravenous polyspecific immunoglobulin G (IVIG) as adjunctive therapy in streptococcal toxic shock syndrome (STSS). Mortality rate; Decrease in the sepsis-related organ failure assessment score in the IVIG group; Increase in plasma neutralizing...

  • Comparison of treatments for Guillain-Barre syndrome. Walling, Anne D. // American Family Physician;5/15/1997, Vol. 55 Issue 7, p2510 

    Presents a summary of the article `Plasma Exchange/Sandoglobulin Guillain-Barre Syndrome Trial Group: Randomized Trial of Plasma Exchange, Intravenous Immunoglobulin and Combined Treatments in Guillain-Barre Syndrome,' from `Lancet,' 1997. Role of plasma exchange and intravenous immunoglobulin...

  • Review: Plasma exchange or intravenous immunoglobulin reduces disability in the Guillain-Barré syndrome.  // ACP Journal Club;May/Jun2004, Vol. 140 Issue 3, p76 

    This article presents a study, which states that in patients with the Guillain-Barr é syndrome (GBS), immunotherapy is consisting of plasma exchange, intravenous immunoglobulin (IgIV), or steroids are effective for reducing GBS-related disability. Studies were selected if they were randomized...

  • Review: Plasma exchange or intravenous immunoglobulin reduces disability in the Guillain-Barré syndrome: COMMENTARY. Bleck, Thomas P. // ACP Journal Club;May/Jun2004, Vol. 140 Issue 3, p76 

    The value of treating patients with Guillain-Barr syndrome (GBS) with plasma exchange or intravenous immunoglobulin (IgIV) is beyond dispute. However, data from randomized clinical trials do not help a clinician choose between the agents for individual patients. This choice should consider the...

  • Lenalidomide cutaneous adverse event: a case of Stevens-Johnson syndrome (SJS) in a primary plasma cell leukaemia patient treated with lenalidomide and dexamethasone. Siniscalchi, A.; Tendas, A.; Morino, L.; Dentamaro, T.; Bellis, A.; Perrotti, A.; Fabritiis, P.; Musto, P.; Caravita, T. // Supportive Care in Cancer;Jul2012, Vol. 20 Issue 7, p1585 

    The article describes a case of a Stevens-Johnson syndrome (SJS) that developed in plasma cell leukaemia during Revlimid and dexamethasone treatment in a 51-year-old man. The laboratory test results of the patient is presented, which include leukocytosis with peripheral plasma cells,...

  • 10 year-old-girl with life-threatening idiopathic systemic capillary leak syndrome: a case report. Iwasa, Tadashi; Ohashi, Hiroyuki; Kihira, Kentaro; Koike, Yuhki; Otake, Kohei; Inoue, Mikihiro; Sawada, Hirofumi; Toyoda, Hidemi; Komada, Yoshihiro // BMC Pediatrics;2014, Vol. 14 Issue 1, p1 

    Background Idiopathic systemic capillary leak syndrome (ISCLS) is a rare disorder, characterized by episodic life-threatening hypotension, hypoalbuminemia, and hemoconcentration. Case presentation A 10 year old girl presented with abdominal pain, vomiting, diarrhea, fever and developed...

  • Intravenous Immunoglobulin in Autoimmune Neuromuscular Diseases. Dalakas, Marinos C. // JAMA: Journal of the American Medical Association;5/19/2004, Vol. 291 Issue 19, p2367 

    Context Intravenous immunoglobulin (IVIG) enhances immune homeostasis by modulating expression and function of Fc receptors, interfering with activation of complement and production of cytokines, providing anti-idiotypic antibodies, and affecting the activation and effector functions of T and B...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics